Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia
ClinicalTrials.gov study NCT02996617. IPD Sharing: NO. Countries: 1. Publications: 7.
Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00089115. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00220285. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of the Combination of AFM13 and Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT02665650. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00060671. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma With TriCAR-T_CD19
ClinicalTrials.gov study NCT03497533. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
A Study of ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02914938. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00882895. IPD Sharing: NO. Countries: 1. Publications: 1.
A Randomized Study of Iodine-131 Anti-b1 Antibody Versus Anti-b1 Antibody in Chemotherapy-relapsed/Refractory Low-grade or Transformed Low-grade Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT01573000. IPD Sharing: YES. Countries: 0. Publications: 0.
SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00900484. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00636311. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00110071. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04545762. IPD Sharing: NO. Countries: 1. Publications: 1.
Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00079261. IPD Sharing: Not stated. Countries: 5. Publications: 1.
A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT01990534. IPD Sharing: YES. Countries: 7. Publications: 0.
A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00322985. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT04809467. IPD Sharing: YES. Countries: 7. Publications: 0.
PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma
ClinicalTrials.gov study NCT05922904. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bortezomib and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00093769. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00002745. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.